Objective: Our study aims to measure the expression level of serum microRNA-205 (miRNA-205, miR-205) in breast cancer, and evaluate the diagnostic value of miR-205 as a noninvasive biomarker for the early detection of breast cancer and other human cancers through a meta-analysis.

Methods: In the first phase, an experiment based on 58 breast cancer patients and 93 healthy controls was carried out to figure out the diagnostic performance of serum miR-205 for breast cancer. The study was conducted by using Reverse Transcription and quantitative Real-time polymerase Cycle Reaction (RT-qPCR). In the second phase, a meta-analysis was performed to evaluate the diagnostic value of miR-205 for various cancers.

Results: The test showed that the normalized expression levels of miR-205 in serum were evidently higher in healthy control than in breast cancer with a sensitivity and specificity at the optimal cutoff of 86.2% and 82.8%, respectively. The meta-analysis received a sensitivity of 75% and a specificity of 84%, and an AUC of 0.87.

Conclusion: Our study determined that as a noninvasive and accessible biomarker, miR-205 not only has high clinical diagnostic value in the detection of breast cancer, but also plays an important role in clinical utilization of diagnosing various cancers. Further researches based on larger-scale subjects and additional improvement should be carried out to confirm our results.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402927PMC

Publication Analysis

Top Keywords

breast cancer
28
mir-205 breast
12
serum mir-205
8
human cancers
8
evaluate diagnostic
8
diagnostic mir-205
8
detection breast
8
mir-205
7
breast
7
cancer
7

Similar Publications

Aim: Breast cancer is the second most common cancer among women and the leading cause of cancer-related mortality in this population. Numerous factors have been identified as either risk factors or protective factors for breast cancer. However, the role of Vitamin D (Vit.

View Article and Find Full Text PDF

Purpose: To investigate the effects of compression therapy combined with exercise for cancer patients (EXCAP) in patients with peripheral neuropathy caused by breast cancer chemotherapy.

Methods: Overall, 108 patients with peripheral neuropathy after chemotherapy for breast cancer were randomly divided into the control group (routine nursing), experimental group 1 (compression therapy), and experimental group 2 (compression therapy and EXCAP). The National Institute of Cancer Drug Toxicity Rating Scale and the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool were assessed and compared between groups.

View Article and Find Full Text PDF

Purpose: Over 50% of households in the United States have at least one musician-many musicians are also breast cancer survivors. This group has not been well studied, and given the level of fine sensory-motor skill required for musicianship, we hypothesized that musicians experience unique manifestations of breast cancer treatment toxicities.

Methods: A nine-item Musical Toxicity Questionnaire (MTQ) was distributed to patients who had consented to participate in the Mayo Clinic Breast Cancer Registry.

View Article and Find Full Text PDF

Rare Indocyanine-Induced Anaphylactic Shock During Deep Inferior Epigastric Artery Perforator Breast Reconstruction: A Case Report.

Ann Plast Surg

February 2025

From the Department of Plastic and Reconstructive Surgery, Ewha Womans University College of Medicine, Mokdong Hospital, Seoul, Republic of Korea.

Indocyanine green (ICG) is a water-soluble green substance that is detectable through infrared cameras and emits greenish light. Approved for medical use in the 1950s, ICG has gained prominence as a real-time visualization tool. Widely recognized as a generally safe substance, ICG is applied in diverse fields.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!